ForbesNew Drug Class Slashes 'Bad' Cholesterol, Review FindsU.S. News & World ReportMONDAY, April 27, 2015 (HealthDay News) -- A new class of cholesterol drug could sharply cut "bad" LDL cholesterol in people who don't fare well on commonly used cholesterol-lowering medications called statins, a new research review confirms.More Preliminary Signs That The New Cholesterol Drugs May Improve OutcomesForbesPCSK9 Inhibitors Appear to Lower Death RiskMedPage TodayMeta-analysis: PCSK9 inhibitors reduce mortality, MIHealioall 7 news articles »
New Drug Class Slashes 'Bad' Cholesterol, Review Finds
Rating: 4.5
Diposkan Oleh: Unknown
